+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Coxsackievirus B3 infection compromises endothelial-dependent vasodilation of coronary resistance arteries



Coxsackievirus B3 infection compromises endothelial-dependent vasodilation of coronary resistance arteries



Journal of Cardiovascular Pharmacology 43(1): 39-47



The mechanisms of coronary artery dysfunction in coxsackievirus B3 (CVB3)-mediated viral myocarditis are poorly understood. We used pressure myography of mouse septal coronary arteries to determine the early and late effects of CVB3 infection on vascular function. Male CD-1 mice (age 6-7 weeks) were infected with CVB3 (1.75 x 10(10) pfu, i.p.). Control mice were injected with PBS. Mice were killed at 3, 7, and 42 days post infection, and the ventricular septal artery was dissected and mounted on a pressure myograph. Pressure-induced myogenic tone was similar in CVB3-infected and sham-infected mice at 3 and 7 days post infection. However, at 42 days post infection constriction of septal arteries to pressures equal to or less than 60 mm Hg was enhanced in CVB3-infected mice compared with sham controls. Agonist-induced vasodilation, as assessed by response to acetylcholine (1 nM-3 microM), was unaltered at early time points (days 3 and 7) in CVB3-infected mice. At later time points (day 42), there was a significant decrease in ACh-induced vasodilation in CVB3-infected mice. Bosentan, an ET-1 (ETA and ETB) receptor antagonist, did not completely ameliorate the reduced ACh-induced vasodilation in 42-day infected mice, indicating that ET-1 does not contribute to vascular dysfunction. Smooth muscle function, as measured by constriction to KCl or dilation to sodium nitroprusside, was unchanged in infected mice at early and late time points. Immunohistochemistry and ET-1 immunoassay were then performed to assess ET-1 levels in CVB3- and sham-infected hearts. There were no differences in ET-1 protein localization or levels at 42 days post infection in sham- and CVB3-infected animals. Finally, in situ hybridization and TUNEL staining were performed to assess viral localization and cell death in CVB3-infected hearts. There was no detectable CVB3 or TUNEL positivity in the endothelium of coronary arteries. Therefore, late impairment of endothelial-dependent vasorelaxation of coronary resistance vessels in CVB3-induced myocarditis does not appear to involve altered ET-1 expression but may be secondary to decreased stimulated NO secretion by the endothelium.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048679106

Download citation: RISBibTeXText

PMID: 14668566


Related references

Coxsackievirus B3 Infection Compromises Endothelial-Dependent Vasodilation of Coronary Resistance Arteries. Journal of Cardiovascular Pharmacology 43(1): 39-47, 2004

Endothelial dependent release of nitric oxide is a significant component of adenosine vasodilation in porcine coronary conduit and resistance arteries. Circulation 96(8 Suppl. ): I139, 10/21/97, 1997

Myocardial ischemia and reperfusion blunt endothelium dependent vasodilation and augment vasoconstriction in canine coronary resistance arteries. Clinical Research 35(1): 114A, 1987

Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25(2): 201-206, 1995

Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. Journal of Surgical Research 110(2): 413-418, 2003

Overexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus. Human Gene Therapy 23(11): 1166-1175, 2012

Impaired endothelium dependent coronary vasodilation in patients with angina pectoris and normal coronary arteries. Journal of the American College of Cardiology 17(2 Suppl. A): 173A, 1991

Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. American Journal of Cardiology 82(12): 1535-9 A7-8, 1998

Impaired Coronary Endothelium-Dependent Vasodilation Is Associated With Microalbuminuria in Patients With Type 2 Diabetes and Angiographically Normal Coronary Arteries. Diabetes care 29(1): 107-112, 2006

Endothelial-dependent vasodilation in peripheral arteries of exercise-trained swine. Medicine & Science in Sports & Exercise 25(5 Suppl. ): S6, 1993

Non-endothelial endothelin counteracts hypoxic vasodilation in porcine large coronary arteries. Bmc Physiology 11(1): 8, 2011

Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 79(5): 1043-1051, 1989

Chronic endotoxemia and endothelium-dependent vasodilation in coronary arteries. Shock 6(4): 267-273, 1996

Effect of ceramide on endothelium-dependent vasodilation in coronary arteries. FASEB Journal 14(4): A164, 2000

Amiodarone causes endothelium-dependent vasodilation in canine coronary arteries. Arquivos Brasileiros de Cardiologia 84(3): 251-255, 2005